PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ICES, Toronto, Ontario, Canada.\', \'Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.\', \'Public Health Ontario, Toronto, Ontario, Canada.\', \'Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.\', \'School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.\', \'Children\'s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.\', \'Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.\', \'Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, WI, USA.\', \'Women\'s College Hospital, Toronto, Ontario, Canada.\', \'Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.\', \'Bruyere and Ottawa Hospital Research Institutes, Ottawa, Ontario, Canada.\', \'ICES, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\', \'Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\', \'Public Health Ontario, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\', \'Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\', \'Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\', \'University Health Network, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41564-021-01053-0
?:doi
?:hasPublicationType
?:journal
  • Nature microbiology
is ?:pmid of
?:pmid
?:pmid
  • 35132198
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.139
?:rankingScore_hIndex
  • 24
?:title
  • Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all